Vuk Stambolic
- Molecular Biology top 0.5%
- Oncology top 1%
- Cancer Research top 1%
- Cell Biology top 1%
- Immunology top 2%
- Co-authors
- James R. WoodgettTak W. MakLaurent RuelAkira SuzukiPamela J. GoodwinRyan J.O. DowlingTakehiko SasakiJosé Luís de la Pompa
- Topics
- PI3K/AKT/mTOR signaling in cancer (35 papers)Metabolism, Diabetes, and Cancer (31 papers)Cancer-related Molecular Pathways (22 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Vuk Stambolic
82 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Molecular Biology 8.6k
- Oncology 2.5k
- Cancer Research 1.6k
- Cell Biology 1.1k
- Immunology 1.0k
Countries citing papers authored by Vuk Stambolic
This map shows the geographic impact of Vuk Stambolic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vuk Stambolic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vuk Stambolic more than expected).
Fields of papers citing papers by Vuk Stambolic
This network shows the impact of papers produced by Vuk Stambolic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vuk Stambolic. The network helps show where Vuk Stambolic may publish in the future.
Co-authorship network of co-authors of Vuk Stambolic
This figure shows the co-authorship network connecting the top 25 collaborators of Vuk Stambolic. A scholar is included among the top collaborators of Vuk Stambolic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vuk Stambolic. Vuk Stambolic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 11 | |
| 3 | 17 | |
| 4 | 21 | |
| 5 | 12 | |
| 6 | 9 | |
| 7 | 46 | |
| 8 | 73 | |
| 9 | 73 | |
| 10 | 11 | |
| 11 | 322 | |
| 12 | 278 | |
| 13 | 54 | |
| 14 | 145 | |
| 15 | 146 | |
| 16 | 78 | |
| 17 | Regulation of PTEN Transcription by p53breakdown → | 753 |
| 18 | Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENbreakdown → | 2061 |
| 19 | 118 | |
| 20 | Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsbreakdown → | 1151 |
About Vuk Stambolic
Vuk Stambolic is a scholar working on Oncology, Molecular Biology and Cell Biology, having authored 85 papers that have together received 10.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (35 papers), Metabolism, Diabetes, and Cancer (31 papers) and Cancer-related Molecular Pathways (22 papers). The work is most often cited by research in Molecular Biology (8.6k citations), Cancer Research (1.6k citations) and Oncology (2.5k citations). Vuk Stambolic has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include James R. Woodgett, Tak W. Mak, Laurent Ruel, Akira Suzuki, Pamela J. Goodwin, Ryan J.O. Dowling, Takehiko Sasaki, José Luís de la Pompa, Jürgen Ruland and Josef Penninger. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.